|
8
|
36
|
1tz5A |
[pnpy19-23]-hpp bound to dpc micelles |
|
0
|
31
|
1t0cA |
Solution structure of human proinsulin c-peptide |
|
5
|
30
|
1t1pB |
Nmr structure of human insulin mutant his-b10-asp, val-b12-thr, pro-b28-lys, lys-b29-pro, 15 structures |
|
103
|
250
|
1t5zA |
Crystal structure of the androgen receptor ligand binding domain (lbd) with dht and a peptide derived from its physiological coactivator ara70 |
|
10
|
30
|
1t5qA |
Solution structure of gip(1-30)amide in tfe/water |
|
2
|
11
|
1t5zB |
Crystal structure of the androgen receptor ligand binding domain (lbd) with dht and a peptide derived from its physiological coactivator ara70 |
|
3
|
14
|
1t63B |
Crystal structure of the androgen receptor ligand binding domain with dht and a peptide derived from its physiological coactivator grip1 nr box3 |
|
5
|
21
|
1t1pA |
Nmr structure of human insulin mutant his-b10-asp, val-b12-thr, pro-b28-lys, lys-b29-pro, 15 structures |
|
0
|
7
|
1t65B |
Crystal structure of the androgen receptor ligand binding domain with dht and a peptide derived form its physiological coactivator grip1 nr box 2 bound in a non-helical conformation |
|
3
|
30
|
1t1qB |
Nmr structure of human insulin mutant his-b10-asp, val-b12-aba, pro-b28-lys, lys-b29-pro, 15 structures |
|
4
|
30
|
1t1kB |
Nmr structure of human insulin mutant his-b10-asp, val-b12-ala, pro-b28-lys, lys-b29-pro, 15 structures |
|
3
|
21
|
1t1qA |
Nmr structure of human insulin mutant his-b10-asp, val-b12-aba, pro-b28-lys, lys-b29-pro, 15 structures |
|
3
|
21
|
1t1kA |
Nmr structure of human insulin mutant his-b10-asp, val-b12-ala, pro-b28-lys, lys-b29-pro, 15 structures |
|
101
|
250
|
1t63A |
Crystal structure of the androgen receptor ligand binding domain with dht and a peptide derived from its physiological coactivator grip1 nr box3 |
|
98
|
251
|
1t65A |
Crystal structure of the androgen receptor ligand binding domain with dht and a peptide derived form its physiological coactivator grip1 nr box 2 bound in a non-helical conformation |
|
148
|
497
|
1rtkA |
Crystal structure analysis of the bb segment of factor b complexed with 4-guanidinobenzoic acid |
|
7
|
36
|
1ru5A |
Solution structure of porcine peptide yy (ppyy) |
|
6
|
30
|
1rweB |
Enhancing the activity of insulin at receptor edge: crystal structure and photo-cross-linking of a8 analogues |
|
44
|
234
|
1si5H |
Protease-like domain from 2-chain hepatocyte growth factor |
|
7
|
36
|
1ruuA |
Solution structure of porcine peptide yy (ppyy) bound to dpc micelles |
|
27
|
138
|
1shxA |
Ephrin a5 ligand structure |
|
5
|
21
|
1rweA |
Enhancing the activity of insulin at receptor edge: crystal structure and photo-cross-linking of a8 analogues |
|
53
|
199
|
1rw5A |
Solution structure of human prolactin |
|
1
|
21
|
1sf1A |
Nmr structure of human insulin under amyloidogenic condition, 15 structures |
|
32
|
131
|
1scfA |
Human recombinant stem cell factor |
|
2
|
30
|
1sf1B |
Nmr structure of human insulin under amyloidogenic condition, 15 structures |
|
10
|
81
|
1rh7A |
Crystal structure of resistin-like beta |
|
31
|
144
|
1rj7A |
Crystal structure of eda-a1 |
|
16
|
103
|
1reuA |
Structure of the bone morphogenetic protein 2 mutant l51p |
|
1
|
7
|
1rdtE |
Crystal structure of a new rexinoid bound to the rxralpha ligand binding doamin in the rxralpha/ppargamma heterodimer |
|
79
|
229
|
1rdtA |
Crystal structure of a new rexinoid bound to the rxralpha ligand binding doamin in the rxralpha/ppargamma heterodimer |
|
20
|
107
|
1rmjA |
C-terminal domain of insulin-like growth factor (igf) binding protein-6: structure and interaction with igf-ii |
|
38
|
141
|
1rg8A |
Human acidic fibroblast growth factor (hafgf-1) at 1.10 angstrom resolution (140 amino acid form) |
|
33
|
140
|
1rj8A |
The crystal structure of tnf family member eda-a2 |
|
93
|
272
|
1rdtD |
Crystal structure of a new rexinoid bound to the rxralpha ligand binding doamin in the rxralpha/ppargamma heterodimer |
|
2
|
9
|
1rdtB |
Crystal structure of a new rexinoid bound to the rxralpha ligand binding doamin in the rxralpha/ppargamma heterodimer |
|
19
|
89
|
1rgxA |
Crystal structure of resisitin |
|
14
|
100
|
1ri0A |
Nmr structure of the n-terminal hath domain of human hdgf |
|
16
|
89
|
1rfxA |
Crystal structure of resisitin |
|
0
|
13
|
1qg1I |
Growth factor receptor binding protein sh2 domain complexed with an shc-derived peptide |
|
30
|
131
|
1qqlA |
The crystal structure of fibroblast growth factor 7/1 chimera |
|
25
|
113
|
1qwhA |
A covalent dimer of transthyretin that affects the amyloid pathway |
|
13
|
104
|
1qg1E |
Growth factor receptor binding protein sh2 domain complexed with an shc-derived peptide |
|
4
|
13
|
1qfaA |
Structure of a neuropeptide y y2 agonist |
|
16
|
132
|
1qqkA |
The crystal structure of fibroblast growth factor 7 (keratinocyte growth factor) |
|
38
|
140
|
1pzzA |
Crystal structure of fgf-1, v51n mutant |
|
37
|
141
|
1q03A |
Crystal structure of fgf-1, s50g/v51g mutant |
|
32
|
138
|
1q1uA |
Crystal structure of human fhf1b (fgf12b) |
|
4
|
30
|
1q4vB |
Crystal structure of allo-ilea2-insulin, an inactive chiral analogue: implications for the mechanism of receptor |
|
10
|
70
|
1pmxA |
Insulin-like growth factor-i bound to a phage-derived peptide |
